RETRANSPLANTATION OF LIVER - A COMPARISON OF FK-506-TREATED AND CYCLOSPORINE-TREATED PATIENTS

被引：0
|
作者：
TAKAYA, S [1 ]
BRONSTHER, O [1 ]
TODO, S [1 ]
ABUELMAGD, K [1 ]
JAIN, A [1 ]
ALESSIANI, M [1 ]
MADARIAGA, J [1 ]
MARINO, IR [1 ]
SELBY, R [1 ]
FUNG, JJ [1 ]
GORDON, RD [1 ]
STARZL, TE [1 ]
机构：
[1] UNIV PITTSBURGH,MED CTR,DEPT SURG,3601 5TH AVE,FALK CLIN,PITTSBURGH,PA 15213
来源：
TRANSPLANTATION PROCEEDINGS | 1991年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3026 / 3028
页数：3
相关论文
共 50 条
  • [21] Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients
    Gómez, R
    Moreno, E
    Colina, F
    Loinaz, C
    Gonzalez-Pinto, I
    Lumbreras, C
    Perez-Cerdá, F
    Castellón, C
    García, I
    JOURNAL OF HEPATOLOGY, 1998, 28 (01) : 150 - 156
  • [22] LACK OF CORRELATION BETWEEN THE MAGNITUDE OF PRESERVATION INJURY AND NEED FOR OKT3 OR CONVERSION TO FK506 IN CYCLOSPORINE-TREATED PRIMARY LIVER ALLOGRAFT RECIPIENTS
    SHACKLETON, CR
    MELINEK, J
    MILLIS, JM
    OLTHOFF, KM
    IMAGAWA, DK
    JURIM, O
    SHAKED, A
    MCDIARMID, SV
    MARTIN, P
    GOLDSTEIN, L
    BUSUTTIL, RW
    HEPATOLOGY, 1994, 20 (04) : A125 - A125
  • [23] Screening for hypomagnesemia in cyclosporine or FK 506 treated renal transplant recipients.
    Gupta, BK
    Glicklich, D
    TRANSPLANTATION, 1999, 67 (07) : S152 - S152
  • [24] Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine
    Sahar, G
    Berman, M
    Ben-Gal, T
    Sahar, E
    Kogan, A
    Michowitch, R
    Saute, M
    Kramer, M
    Sagie, A
    Shapira, Y
    Aravot, D
    Vidne, BA
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 678 - 678
  • [25] THE SPECTRUM OF ASPERGILLOSIS IN LIVER-TRANSPLANT PATIENTS - COMPARISON OF FK-506 AND CYCLOSPORINE IMMUNOSUPPRESSION
    TORRECISNEROS, J
    MANEZ, R
    KUSNE, S
    ALESSIANI, M
    MARTIN, M
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3040 - 3041
  • [26] Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine
    Satterthwaite, R
    Aswad, S
    Sunga, V
    Shidban, H
    Bogaard, T
    Asai, P
    Khetan, U
    Akra, I
    Mendez, RG
    Mendez, R
    TRANSPLANTATION, 1998, 65 (03) : 446 - 449
  • [27] Comparison of FK506 and cyclosporine - Reply
    Gjertson, DW
    Cecka, JM
    TRANSPLANTATION, 1996, 62 (05) : 702 - 702
  • [28] ALPHA-INTERFERON TREATMENT OF HEPATITIS-C IN PATIENTS WITH LIVER ALLOGRAFTS TREATED WITH EITHER FK-506 OR CYCLOSPORINE-A
    VANTHIEL, DH
    BADDOUR, N
    FAGIUOLI, S
    WRIGHT, HI
    GAVALER, JS
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (09) : 787 - 791
  • [29] RANITIDINE AND THE CYCLOSPORINE-TREATED RECIPIENT - REPLY
    KAHAN, BD
    JAROWENKO, MV
    TRANSPLANTATION, 1989, 48 (02) : 359 - 359
  • [30] EFFECT OF DISOPYRAMIDE IN A CYCLOSPORINE-TREATED PATIENT
    NANNI, G
    MAGALINI, SC
    SERINO, F
    CASTAGNETO, M
    TRANSPLANTATION, 1988, 45 (01) : 257 - 257
12345